Decoy Therapeutics Inc. (DCOY)

NCM – Real Time Price. Currency in USD

3.77

-0.10 (-2.58%)

Market open: Aug 12, 2026, 10:39 AM EDT

3.80

-0.07 (-1.81%)

Previous after-hours: Aug 11, 2026, 5:46 PM EDT

03.08.2026

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, protecting antiviral peptide conjugates, the methods used to make them, their formulations, and the design platform behind them CAMBRIDGE, Mass., Aug. 3, 2026 /PRNewswire/ -- Decoy Therapeutics Inc. (Nasdaq: DCOY), a biotechnology company developing Designable Multi-Antivirals (D-MAVs™), today announced continued expansion of its intellectual property portfolio, which now comprises seven patent families covering compositions of matter, methods of manufacture, formulations, and the company's IMP³ACT™ design platform.

Videos

No Data

There is no data to display

Press releases

03.08.2026

Decoy Therapeutics Inc. (DCOY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Videos

No Data

Press releases

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Videos

No Data

Press releases

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Search stocks

Decoy Therapeutics Inc. (DCOY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Videos

No Data

Press releases

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform

Videos

No Data

Press releases

Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform